Chinese Society of Cardiology guidelines on the diagnosis and treatment of adult fulminant myocarditis
Chinese Society of Cardiology, Chinese Medical Association, Writing Group,Jiangang Jiang,Hongyang Shu,Dao Wen Wang,Rutai Hui,Chenze Li,Xiao Ran,Hong Wang,Jing Zhang,Shaoping Nie,Guanglin Cui,Dingcheng Xiang,Qun Shao,Shengyong Xu,Ning Zhou,Yuming Li,Wei Gao,Yuguo Chen,Yuan Bian,Guoping Wang,Liming Xia,Yan Wang,Chunxia Zhao,Zhiren Zhang,Yuhua Zhao,Jianan Wang,Shaoliang Chen,Hong Jiang,Jing Chen,Xianjin Du,Mao Chen,Yinxian Sun,Sheng Li,Hu Ding,Xueping Ma,Hesong Zeng,Li Lin,Shenghua Zhou,Likun Ma,Ling Tao,Juan Chen,Yiwu Zhou,Xiaomei Guo
DOI: https://doi.org/10.1007/s11427-023-2421-0
2024-02-10
Science China Life Sciences
Abstract:Fulminant myocarditis is an acute diffuse inflammatory disease of myocardium. It is characterized by acute onset, rapid progress and high risk of death. Its pathogenesis involves excessive immune activation of the innate immune system and formation of inflammatory storm. According to China's practical experience, the adoption of the "life support-based comprehensive treatment regimen" (with mechanical circulation support and immunomodulation therapy as the core) can significantly improve the survival rate and long-term prognosis. Special emphasis is placed on very early identification,very early diagnosis,very early prediction and very early treatment.
biology